• Science & Technology

New Year’s Honours 2018: Professor Caroline Dive, CBE, and her career in lung cancer research

Our researcher, Professor Caroline Dive, has received a CBE in this year's New Year's Honours list. We spoke to her about her outstanding career. Our researcher, Professor Caroline Dive, has received a CBE in this year's New Year's Honours list. We spoke to her about her outstanding career.

30 December 2017

• Health & Medicine
• Science & Technology

2017 cancer research highlights: a patient's pick

Patients are at the heart of what we do, so we asked a pancreatic cancer survivor to pick the 2017 cancer research highlights that matter to him. Patients are at the heart of what we do, so we asked a pancreatic cancer survivor to pick the 2017 cancer research highlights that matter to him.

20 December 2017

• Science & Technology

Cancer Research UK announces drug discovery collaboration with Celgene Corporation

Cancer Research UK announces the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology, and Celgene Corporation Cancer Research UK announces the signing of a five-year drug-discovery collaboration between its subsidiary, Cancer Research Technology, and Celgene Corporation

15 December 2017

• Health & Medicine

Immune cell therapy results are 'landmark moment' in lymphoma treatment

Four in 10 patients with aggressive lymphoma were cancer-free 15 months after treatment with engineered immune cells, according to new clinical trial results. Four in 10 patients with aggressive lymphoma were cancer-free 15 months after treatment with engineered immune cells, according to new clinical trial results.

12 December 2017

• Health & Medicine

Breast cancer less likely to come back with more intensive chemo

Giving chemotherapy in higher average doses reduces the risk of early stage breast cancer coming back, according to new unpublished results. Giving chemotherapy in higher average doses reduces the risk of early stage breast cancer coming back, according to new unpublished results.

8 December 2017

• Science & Technology

Blood test could predict skin cancer's return

Scientists have discovered that testing skin cancer patients’ blood for tumour DNA could help predict the chances of an aggressive cancer returning. Scientists have discovered that testing skin cancer patients’ blood for tumour DNA could help predict the chances of an aggressive cancer returning.

6 December 2017

• Science & Technology

Tackling ‘undruggable’ genes in lung and pancreatic cancers is this researcher’s life

Two important cancer genes cooperate to make lung cancers more aggressive in mice, according to new research. Two important cancer genes cooperate to make lung cancers more aggressive in mice, according to new research.

30 November 2017

• Health & Medicine

Immune-boosting antibody combination could improve lymphoma survival

Combining two different immunotherapy treatments could dramatically improve lymphoma survival. Combining two different immunotherapy treatments could dramatically improve lymphoma survival.

30 November 2017

• Science & Technology

Gut bacteria might hitch a ride with spreading bowel cancer cells

Bacteria found in certain bowel cancers can also be found inside a small number of tumours that have spread to another part of the body, says new research. Bacteria found in certain bowel cancers can also be found inside a small number of tumours that have spread to another part of the body, says new research.

24 November 2017

• Science & Technology
• Health & Medicine

Experimental drug trial seeks to improve treatment for head and neck cancer

A trial to test an experimental drug in patients with head and neck cancer launches in the UK through the Combinations Alliance. A trial to test an experimental drug in patients with head and neck cancer launches in the UK through the Combinations Alliance.

24 November 2017

• Health & Medicine

Risk of certain breast cancers coming back remains for at least 20 years after treatment

New research says the risk of a certain type of breast cancer coming back in other parts of the body stays constant for at least 20 years after treatment. New research says the risk of a certain type of breast cancer coming back in other parts of the body stays constant for at least 20 years after treatment.

8 November 2017